| LJPC Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LJPC shares outstanding history going back to 1/14/2014:
Also see: LJPC Market Cap History LJPC YTD Return |
LJPC Shares Outstanding History — La Jolla Pharmaceutical Share Count Over Time
As of 8/1/2022 La Jolla Pharmaceutical has 24.94 million LJPC shares outstanding. Investors often track the LJPC shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows LJPC share count trends over time, with 41 historical shares outstanding datapoints presented, dating back to 1/14/2014.
| LJPC Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LJPC Historical Shares Outstanding: +22.49% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LJPC Stock Price Chart |
| About La Jolla Pharmaceutical Co. |
| La Jolla Pharmaceutical is focused on the commercialization of therapies. GIAPREZA™ (angiotensin II) injection is a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. XERAVA™ (eravacycline) for injection is a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections. Co. owns various product candidates that are in preclinical development including: TP-6076, an IV formulation of a synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. We show 41 historical shares outstanding datapoints in our coverage of LJPC's shares outstanding history. Understanding the changing numbers of LJPC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LJPC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LJPC by allowing them to research LJPC shares outstanding history as well as any other stock in our coverage universe. |
| LJPC Current Stock Quote |
Quotes delayed 20 minutes  Free LJPC Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| LJPC Share Performance |
| Shares Outstanding Peers |
| La Jolla Pharmaceutical (LJPC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
LLY Shares Outstanding History LMAT Shares Outstanding History LMNX Shares Outstanding History LNSR Shares Outstanding History LNTH Shares Outstanding History LONA Shares Outstanding History LOXO Shares Outstanding History LPCN Shares Outstanding History LPNT Shares Outstanding History LPTX Shares Outstanding History More Healthcare companies » |
LJPC Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
